Sec Form 4 Filing - Care Capital III LLC @ Minerva Neurosciences, Inc. - 2015-01-22

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Care Capital III LLC 2. Issuer Name and Ticker or Trading Symbol Minerva Neurosciences, Inc. [ NERV] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 47 HULFISH STREET, SUITE 310 3. Date of Earliest Transaction (MM/DD/YY) 01/22/2015 (Street) PRINCETON, NJ08542 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/22/2015 S 395,697 ( 1 ) D $ 5.11 ( 2 ) 2,955,707 I See footnote ( 3 ) Common Stock 01/23/2015 S 63,304 ( 4 ) D $ 5.14 ( 5 ) 2,892,403 I See footnote ( 6 ) Common Stock 01/26/2015 S 23,111 ( 7 ) D $ 5.02 ( 8 ) 2,869,292 I See footnote ( 9 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Care Capital III LLC 47 HULFISH STREET SUITE 310 PRINCETON, NJ08542 X Care Capital Investments III L.P. 47 HULFISH STREET SUITE 310 PRINCETON, NJ08542 X Care Capital Offshore Investments III LP 47 HULFISH STREET SUITE 310 PRINCETON, NJ08542 X Signatures Care Capital III, LLC /s/ David R. Ramsay 01/26/2015 Signature of Reporting Person Date Care Capital Investments III L.P., By: Care Capital III, LLC, Its General Partner /s/ David R. Ramsay 01/26/2015 Signature of Reporting Person Date Care Capital Offshore Investments III LP, By: Care Capital III, LLC, Its General Partner /s/ David R. Ramsay 01/26/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares were sold as follows: 389,197 by Care Capital Investments III L.P. and 6,500 by Care Capital Offshore Investments III LP. ( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.00, inclusive. The reporting person undertakes to provide to Minerva Neurosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5) and (8). ( 3 )Consists of 2,907,158 shares held by Care Capital Investments III L.P. and 48,549 shares held by Care Capital Offshore Investments III LP. Care Capital III, LLC is the general partner of Care Capital Investments III L.P. and Care Capital Offshore Investments III LP and as a result, Care Capital III, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital III, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities. ( 4 )The shares were sold as follows: 62,264 by Care Capital Investments III L.P. and 1,040 by Care Capital Offshore Investments III LP. ( 5 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.42 to $5.50, inclusive. ( 6 )Consists of 2,844,894 shares held by Care Capital Investments III L.P. and 47,509 shares held by Care Capital Offshore Investments III LP. ( 7 )The shares were sold as follows: 22,731 by Care Capital Investments III L.P. and 380 by Care Capital Offshore Investments III LP. ( 8 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.11 to $5.00, inclusive. ( 9 )Consists of 2,822,163 shares held by Care Capital Investments III L.P. and 47,129 shares held by Care Capital Offshore Investments III LP.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.